Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS
· Delayed Price · Currency is USD
0.2450
+0.0150 (6.52%)
Jun 2, 2025, 3:45 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $305.04 thousand as of June 2, 2025. Its market cap has decreased by -88.63% in one year.
Market Cap
305.04K
Enterprise Value
-1.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 305.04K, a decrease of -99.06%. That is a compound annual growth rate of -66.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2025 | 305.04K | -83.57% |
Dec 31, 2024 | 1.86M | -50.48% |
Dec 29, 2023 | 3.75M | -48.56% |
Dec 30, 2022 | 7.29M | -81.86% |
Dec 31, 2021 | 40.18M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.60B |
Veradigm | 730.27M |
Nika Pharmaceuticals | 667.04M |
Tian'an Technology Group | 614.49M |
Elite Pharmaceuticals | 576.87M |
Glass House Brands | 452.99M |
CytoDyn | 427.05M |
Northwest Biotherapeutics | 394.36M |